BeOne Medicines terminates CMB credit facility, avoids penalties

BeOne Medicines Ltd. filed an overseas regulatory announcement (Form 8-K) on December 19, 2025, detailing the termination of its credit facility with China Merchants Bank Co., Ltd. (CMB Credit Facility). The company utilized a portion of the proceeds from a new facilities agreement to fully repay all outstanding amounts owed under the CMB Credit Facility.

The termination, effective December 16, 2025, included the cancellation of all commitments by China Merchants Bank to extend further credit, as well as all guarantees and security interests granted by BeOne Medicines to the lender. No termination penalties were incurred by the company.

The new facilities agreement, disclosed on November 19, 2025, involves certain BeOne subsidiaries as guarantors and a consortium of financial institutions. The Hongkong and Shanghai Banking Corporation Limited acts as global coordinator, original mandated lead arranger, bookrunner, agent, and security agent for this strategic financial maneuver.